<DOC>
	<DOCNO>NCT01768403</DOCNO>
	<brief_summary>Centralized Pan-Algerian Survey undertreatment hypercholesterolemia . The purpose study establish proportion patient lipid-lowering pharmacological treatment reach LDL-C goal accord Third Joint European Task Force guideline survey population .</brief_summary>
	<brief_title>Centralised Pan-Algerian Survey Undertreatment Hypercholesterolemia</brief_title>
	<detailed_description>Centralised Pan-Algerian Survey undertreatment hypercholesterolemia .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Subject must provide informed consent comply survey procedure . Subject lipid lower drug treatment least 3 month , dose change minimum 6 week . Subjects unwilling unable provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Coronary Heart disease</keyword>
	<keyword>Peripheral Arterial disease</keyword>
</DOC>